Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez

Dinesh Khanna; Angelika Jahreis; Celia J F Lin

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez

【24h】

Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez

机译：回应：“檀香根的有效性和安全性治疗难治性全身硬化相关的间质性肺病：”Narváez“的案例系列

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2019年第11期|共1页
作者
Dinesh Khanna; Angelika Jahreis; Celia J F Lin;
展开▼
作者单位

Division of RheumatologyUniversity of Michigan;

Product DevelopmentGenentech Inc;

Product DevelopmentGenentech Inc;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
systemic sclerosis; disease activity; pulmonary fibrosis; tocilizumab; CLINICAL TRIAL;

机译：全身硬化;疾病活动;肺纤维化;TOCILIZUMAB;临床试验;

相似文献

外文文献
中文文献
专利

1. Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez [J] . Dinesh Khanna, Angelika Jahreis, Celia J F Lin Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第11期

机译：回应：“檀香根的有效性和安全性治疗难治性全身硬化相关的间质性肺病：”Narváez“的案例系列
2. IMPROVEMENT OF PULMONARY FUNCTION IN A PATIENT WITH INTERSTITIAL LUNG DISEASE SECONDARY TO SYSTEMIC SCLEROSIS AFTER TREATMENT WITH TOCILIZUMAB [J] . Severino A., Vigone B., Beretta L. Clinical and experimental rheumatology . 2014,第2Suppla81期

机译：用特勤素治疗后患有间质肺病患者患者患者肺功能的改善
3. Effectiveness and safety of rituximab for the treatment of refractory systemic sclerosis associated calcinosis: A case series and systematic review of the literature [J] . Narvaez J., Pirola J. P., LLuch J., Autoimmunity reviews . 2019,第3期

机译：利妥昔单抗治疗难治性全身硬化症相关屈曲的有效性和安全性：案例系列与文学系统综述
4. Evaluation of the effectiveness of Sertoli cells to suppress immune responses for the potential use as a safer alternative to systemic immune suppression in clinical islet transplantation for the treatment of type 1 diabetes [D] . Lord, Sarah Jean 2005

机译：评价血液细胞抑制免疫应答的潜在用途的潜在用途，作为临床胰岛移植在临床胰腺移植中的含有型1型糖尿病的替代品
5. Efficacy Safety and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis [O] . Gian Luca Erre, Marco Sebastiani, Maria Antonietta Fenu, 2020

机译：疗效安全性和治疗性肺病相关间质肺病疾病的疗效安全性：系统综述和网络元分析
6. Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez [O] . Dinesh Khanna, Angelika Jahreis, Celia J F Lin 2018

机译：回应：'檀香根治疗难治性全身硬化相关间质性肺病的有效性和安全性：Narváez的案例系列
7. Biomarker-Based Prediction Models for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease. [R] . Assassi, S. 2017

机译：基于生物标志物的系统性硬化相关间质性肺病治疗反应预测模型。

Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez

著录项

相似文献

相关主题

期刊订阅